Multiple myeloma is the second most common blood cancer in the United States, and it is more common in men, with an estimated 20,030 new male cases diagnosed in 2025. Multiple myeloma is the ...
At a median follow-up of 31 months, the rate of spontaneous primary tumor regression was 27%, with a median volume reduction of 60%, the researchers reported. More than a quarter of patients with ...
177Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-Label, Randomized, Controlled, Phase II Study Children ...
Benign intracranial tumors, such as meningiomas, vestibular schwannomas, pituitary adenomas, craniopharyngiomas, hemangioblastomas, and glomus tumors, represent a distinctive challenge in modern neuro ...
Glomus tumors (GTs) are rare neoplasms, classically presenting as subungual lesions with pathognomonic triad of severe paroxysmal pain triggered by cold, pressure, or touch. Extradigital glomus tumors ...
AI models can generate more complete summaries of complex cancer pathology reports than physicians, according to a new Northwestern Medicine study that tested six models developed by Meta, Google, ...
Please provide your email address to receive an email when new articles are posted on . Management and treatment of sarcoma takes a multidisciplinary team. The Musculoskeletal Tumor Registry aims to ...
A new case report was published in Oncotarget's Volume 15 on October 11, 2024, entitled "Complete response to encorafenib plus binimetinib in a BRAF V600E-mutant metastasic malignant glomus tumor." As ...
Radiotherapy can slow the growth of benign tumors. In some cases, radiotherapy may be able to shrink or eliminate a benign tumor. Radiotherapy is often associated with cancer treatment, but it can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results